The BELLA trial will enroll sufferers with platinum-resistant ovarian most cancers on a routine of relacorilant plus chemo and Avastin.BELLA, a part 2 scientific trial evaluating...
Guinigundo is a nurse practitioner and the director of precision oncology for Cincinnati Most cancers Advisors. He sat down with CURE throughout the 42nd Annual Miami Breast...
An knowledgeable explores the challenges sufferers face in accessing lymphedema compression clothes following most cancers remedy.Lymphedema is swelling that occurs when fluid builds up as a...
China’s Heart for Drug Analysis (CDE) of the China Nationwide Medical Merchandise Administration (NMPA) has accredited Japanese pharma main Astellas’ (TYO:4503) Xtandi...